Vitrolife AB (VITR) Stock Statistics & Valuation Metrics

Vitrolife AB has a market cap or net worth of kr21.14B. The enterprise value is ―.

Vitrolife AB has 135,447,190 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vitrolife AB’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.53%.

The current PE Ratio of Vitrolife AB is 56.76. Vitrolife AB’s PEG ratio is -14.53.

In the last 12 months, Vitrolife AB had revenue of 3.61B and earned 513.00M in profits. Earnings per share was 3.79.

In the last 12 months, operating cash flow was 779.00M and capital expenditures -85.00M, giving a free cash flow of 694.00M billion.

Vitrolife AB pays an annual dividend of kr1.1, resulting in a dividend yield of 0.69%

Vitrolife AB upcoming earnings date is Jul 17, 2025, TBA Not Confirmed.

Vitrolife AB as a current ratio of 3.34, with Debt / Equity ratio of 14.86%

In the past 12 months, Vitrolife AB has paid 160.00M in taxes.

Vitrolife AB EV to EBITDA ratio is 38.40, with an EV/FCF ratio of 33.15.

Vitrolife AB has kr1.05B in cash and marketable securities with kr1.95B in debt, giving a net cash position of kr897.00M billion.

Gross margin is 57.52%, with operating margin of 21.70%, and net profit margin of 14.21%.

The average price target for Vitrolife AB is ―, which is 11.43% higher than the current price. The consensus rating is ―